393 related articles for article (PubMed ID: 15367279)
1. Current immunosuppressive agents in pediatric renal transplantation: efficacy, side-effects and utilization.
Smith JM; Nemeth TL; McDonald RA
Pediatr Transplant; 2004 Oct; 8(5):445-53. PubMed ID: 15367279
[TBL] [Abstract][Full Text] [Related]
2. Balancing efficacy and toxicity in kidney-transplant immunosuppression.
Leichtman AB
N Engl J Med; 2007 Dec; 357(25):2625-7. PubMed ID: 18094383
[No Abstract] [Full Text] [Related]
3. Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection.
Burke GW; Ciancio C; Blomberg BB; Rosen A; Suzart K; Roth D; Kupin W; Esquenazi V; Miller J
Transplant Proc; 2002 Aug; 34(5):1610-1. PubMed ID: 12176505
[No Abstract] [Full Text] [Related]
4. Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation.
Ekberg H; Bernasconi C; Tedesco-Silva H; Vítko S; Hugo C; Demirbas A; Acevedo RR; Grinyó J; Frei U; Vanrenterghem Y; Daloze P; Halloran P
Am J Transplant; 2009 Aug; 9(8):1876-85. PubMed ID: 19563339
[TBL] [Abstract][Full Text] [Related]
5. Current status of immunosuppressive agents for solid organ transplantation in children.
Coelho T; Tredger M; Dhawan A
Pediatr Transplant; 2012 Mar; 16(2):106-22. PubMed ID: 22360399
[TBL] [Abstract][Full Text] [Related]
6. Current immunosuppressive agents: efficacy, side effects, and utilization.
Smith JM; Nemeth TL; McDonald RA
Pediatr Clin North Am; 2003 Dec; 50(6):1283-300. PubMed ID: 14710781
[TBL] [Abstract][Full Text] [Related]
7. Can antibody prophylaxis allow sparing of other immunosuppressives?
Vincenti F; Grinyo J; Ramos E; Nashan B; Stuart F; Kuypers D; Brattstrom C; Cho S; Ekberg H; Johnson R
Transplant Proc; 1999; 31(1-2):1246-8. PubMed ID: 10083557
[No Abstract] [Full Text] [Related]
8. Safety and efficacy of mycophenolate mofetil for prophylaxis in Asian renal transplant recipients.
Suhail SM; Vathsala A; Lou HX; Woo KT
Transplant Proc; 2000 Nov; 32(7):1757-8. PubMed ID: 11119922
[No Abstract] [Full Text] [Related]
9. Efficacy and safety of mycophenolate mofetil in different dosages in Asian renal allograft recipients.
Tsang WK; Tong KL; Yeung S; Lee W; Chan HW
Transplant Proc; 2000 Nov; 32(7):1755-6. PubMed ID: 11119921
[No Abstract] [Full Text] [Related]
10. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
11. Steroid withdrawal in renal transplant recipients.
Oppenheimer F
Transplant Proc; 2000 Feb; 32(1A Suppl):14S-15S. PubMed ID: 10686314
[No Abstract] [Full Text] [Related]
12. What is the calcineurin inhibitor of choice for pediatric renal transplantation?
Kari JA; Trompeter RS
Pediatr Transplant; 2004 Oct; 8(5):437-44. PubMed ID: 15367278
[TBL] [Abstract][Full Text] [Related]
13. The role of immunosuppressive drugs in transplantation.
Triemer H
J Med Assoc Ga; 1998 Apr; 87(2):93-6. PubMed ID: 16259250
[No Abstract] [Full Text] [Related]
14. Evaluation of various immunosuppressive regimes in second renal transplants.
Toronyi E; Remport A; Járay J; Máthé Z; Borka P; Perner F
Transplant Proc; 2001 May; 33(3):2315-6. PubMed ID: 11377543
[No Abstract] [Full Text] [Related]
15. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.
Lindenfeld J; Miller GG; Shakar SF; Zolty R; Lowes BD; Wolfel EE; Mestroni L; Page RL; Kobashigawa J
Circulation; 2004 Dec; 110(25):3858-65. PubMed ID: 15611389
[No Abstract] [Full Text] [Related]
16. Daclizumab: novel biologic immunoprophylaxis for prevention of acute rejection in renal transplantation.
Vincenti F
Transplant Proc; 1999 Sep; 31(6):2206-7. PubMed ID: 10500546
[No Abstract] [Full Text] [Related]
17. The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60.
Xenos EX; Ciancio G; Burke GW; Roth D; Miller J
Clin Transplant; 1997 Oct; 11(5 Pt 2):497-9. PubMed ID: 9361949
[TBL] [Abstract][Full Text] [Related]
18. Indications for mycofenolate mofetil therapy after liver transplantation.
Platz KP; Mueller AR; Neuhaus P
Transplant Proc; 1997 Nov; 29(7):2880-1. PubMed ID: 9365601
[No Abstract] [Full Text] [Related]
19. Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
Esmeraldo RM; Donadi MO; Oliveira ML; Ponte CN; Pinheiro PM
Transplant Proc; 1999 Nov; 31(7):3007-8. PubMed ID: 10578367
[No Abstract] [Full Text] [Related]
20. Inferior results with basis immunosuppression with sirolimus in kidney transplantation.
van den Akker JM; Hené RJ; Hoitsma AJ
Neth J Med; 2007 Jan; 65(1):23-8. PubMed ID: 17293636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
